Loading...
Biosimilars and the extrapolation of indications for inflammatory conditions
Extrapolation is the approval of a biosimilar for use in an indication held by the originator biologic not directly studied in a comparative clinical trial with the biosimilar. Extrapolation is a scientific rationale that bridges all the data collected (ie, totality of the evidence) from one indicat...
Na minha lista:
| Udgivet i: | Biologics |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5322938/ https://ncbi.nlm.nih.gov/pubmed/28255229 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S124476 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|